Trade INMB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
INmune Bio Inc. (INMB) is trading at US$2.32, up 1.09% today as of Sep 22, 10:47 EDT. The company has a market capitalisation of US$64.39M. Over the past 52 weeks, INMB has traded between US$1.09 and US$2.60. On Syfe you can trade INMB with $0 commission and add it to your watchlist.
| Previous close | US$2.29 |
|---|---|
| Market cap | US$64.39M |
| 52-week range | US$1.09 – US$2.60 |
| Volume | 306.66K |
| Exchange | US |
Add to Watchlist
Set Price Alert
INmune Bio Inc.
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
Year: 2019
INmune Bio Meets Milestone for CORDStrom Platform; Plans to Apply for BLA With US FDA
Jul 20, 12:37 PM · MT Newswires
INmune Bio Says Study Shows Drug Candidate Reduced Alzheimer's-Related Brain Changes After Brain Injury
Jul 15, 11:50 AM · MT Newswires
Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday
Jul 1, 1:20 PM · MT Newswires
INmune Bio Files US Patent Application for CORDStrom Cell Therapy Platform
Jul 1, 11:41 AM · MT Newswires
INmune Bio Gets UK Approval for Pediatric Plan for RDEB Treatment Candidate
Jun 25, 11:40 AM · MT Newswires
INmune Bio Inc. (INMB) stock is trading at US$2.32, +1.09% from the previous close of US$2.29.
The market cap for INmune Bio Inc. (INMB) stock is approximately US$64.39M.
The 52-week high for INmune Bio Inc. (INMB) stock is US$2.60.
The 52-week low for INmune Bio Inc. (INMB) stock is US$1.09.
INmune Bio Inc. (INMB) does not currently pay a dividend.
Stay on top of INMB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
